- Home
- SGMO vs KNDI Comparison
SGMO vs KNDI Comparison
Compare SGMO & KNDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGMO
- KNDI
- Stock Information
- Founded
- SGMO 1995
- KNDI 2002
- Country
- SGMO United States
- KNDI China
- Employees
- SGMO N/A
- KNDI N/A
- Industry
- SGMO Biotechnology: Biological Products (No Diagnostic Substances)
- KNDI Auto Manufacturing
- Sector
- SGMO Health Care
- KNDI Consumer Discretionary
- Exchange
- SGMO Nasdaq
- KNDI Nasdaq
- Market Cap
- SGMO 122.8M
- KNDI 101.7M
- IPO Year
- SGMO 2000
- KNDI N/A
- Fundamental
- Price
- SGMO $0.64
- KNDI $1.25
- Analyst Decision
- SGMO Strong Buy
- KNDI
- Analyst Count
- SGMO 7
- KNDI 0
- Target Price
- SGMO $5.29
- KNDI N/A
- AVG Volume (30 Days)
- SGMO 4.9M
- KNDI 107.7K
- Earning Date
- SGMO 11-11-2025
- KNDI 11-17-2025
- Dividend Yield
- SGMO N/A
- KNDI N/A
- EPS Growth
- SGMO N/A
- KNDI N/A
- EPS
- SGMO N/A
- KNDI N/A
- Revenue
- SGMO $81,706,000.00
- KNDI $104,035,613.00
- Revenue This Year
- SGMO $28.47
- KNDI N/A
- Revenue Next Year
- SGMO N/A
- KNDI N/A
- P/E Ratio
- SGMO N/A
- KNDI N/A
- Revenue Growth
- SGMO 565.52
- KNDI N/A
- 52 Week Low
- SGMO $0.41
- KNDI $0.89
- 52 Week High
- SGMO $3.18
- KNDI $1.81
- Technical
- Relative Strength Index (RSI)
- SGMO 49.82
- KNDI 48.18
- Support Level
- SGMO $0.62
- KNDI $1.21
- Resistance Level
- SGMO $0.69
- KNDI $1.29
- Average True Range (ATR)
- SGMO 0.05
- KNDI 0.06
- MACD
- SGMO -0.01
- KNDI 0.01
- Stochastic Oscillator
- SGMO 25.77
- KNDI 33.18
About SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.
About KNDI Kandi Technologies Group Inc
Kandi Technologies Group Inc is engaged in developing, manufacturing, and commercializing fully electric vehicle products and related technologies. Its products mainly consist of EV parts, EV products, and off-road vehicles, including All-Terrain Vehicles (ATVs), UTVs, go-karts, electric scooters, electric self-balancing scooters, and associated parts, and Lithium-ion cells, etc. The company generates maximum revenue from the sale of Off-road vehicles and associated parts. Geographically, it derives maximum revenue from the United States and other countries, followed by China.